We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals
ELDN

20 hedge funds and large institutions have $2.78M invested in Eledon Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

54% more funds holding

Funds holding: 13 → 20 (+7)

33% more capital invested

Capital invested by funds: $2.1M → $2.78M (+$683K)

0.24% more ownership

Funds ownership: 1.86% → 2.1% (+0.24%)

Holders
20
Holders Change
+7
Holders Change %
+53.85%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
4
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$690K
2
Renaissance Technologies
Renaissance Technologies
New York
+$112K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$67.8K
4
Citadel Advisors
Citadel Advisors
Florida
+$34K
5
Jane Street
Jane Street
New York
+$26.4K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$369K
2
BlackRock
BlackRock
New York
-$15.2K
3
Victory Capital Management
Victory Capital Management
Texas
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$1.46M – – –
BI
2
BVF Inc
California
$818K +$690K +61,122 +161%
Renaissance Technologies
3
Renaissance Technologies
New York
$291K +$112K +9,886 +39%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$49K +$67.8K +6,012 New
VF
5
Virtu Financial
New York
$42K +$57.7K +5,117 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$25K +$10.7K +950 +45%
Citadel Advisors
7
Citadel Advisors
Florida
$25K +$34K +3,016 New
Jane Street
8
Jane Street
New York
$19K +$26.4K +2,341 New
TSS
9
Two Sigma Securities
New York
$15K +$21.1K +1,869 New
Rockefeller Capital Management
10
Rockefeller Capital Management
New York
$14K – – –
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$8K +$11.5K +1,021 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$5K – – –
Northern Trust
13
Northern Trust
Illinois
$5K +$7.22K +640 New
BCM
14
Bayesian Capital Management
New York
$5K +$7.28K +645 New
BlackRock
15
BlackRock
New York
$3K -$15.2K -1,344 -79%
6CM
16
683 Capital Management
New York
– -$369K -52,567 Closed
Victory Capital Management
17
Victory Capital Management
Texas
– -$2K -275 Closed
Morgan Stanley
18
Morgan Stanley
New York
– +$23 +2 New
PAG
19
Private Advisor Group
New Jersey
– +$68 +6 New
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
– +$124 +11 +79%

ELDN Hedge Fund Activity: Q2 2020 in Review

20 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q2 2020, worth a combined $2.78M — up 33% from $2.1M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ELDN positions and 3 closed out — a net gain of 7 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was BVF Inc, adding an estimated $690K. The largest seller was 683 Capital Management, exiting entirely with an estimated $369K sold.

  • 20 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q2 2020, up from 13 in Q1 2020.
  • Funds reported $2.78M of Eledon Pharmaceuticals stock for Q2 2020, up 33% quarter-over-quarter.
  • 10 funds opened new Eledon Pharmaceuticals positions in Q2 2020 and 3 closed out, a net change of +7 holders.
  • The largest Eledon Pharmaceuticals buyer in Q2 2020 was BVF Inc, an estimated $690K added.
  • The largest Eledon Pharmaceuticals seller in Q2 2020 was 683 Capital Management, an estimated $369K sold.

Based on aggregated 13F filings for Q2 2020.